1. A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia. Issue 6 (20th December 2019) Authors: Narayan, Rupa; Blonquist, Traci M.; Emadi, Ashkan; Hasserjian, Robert P.; Burke, Meghan; Lescinskas, Christopher; Neuberg, Donna S.; Brunner, Andrew M.; Hobbs, Gabriela; Hock, Hanno; McAfee, Steven L.; Chen, Yi‐Bin; Attar, Eyal; Graubert, Timothy A.; Bertoli, Christina; Moran, Jenna A.; Bergeron,... Journal: Cancer Issue: Volume 126:Issue 6(2020) Page Start: 1264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗